Health care stocks were declining late Thursday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) both fractionally lower.
The iShares Biotechnology ETF (IBB) rose 0.4%.
In corporate news, Pfizer (PFE) is collaborating with Atavistik Bio to accelerate the discovery of new precision allosteric therapeutics, Atavistik said. Pfizer shares added 0.5%.
BioNexus Gene Lab (BGLC) shares soared 45%. The company said that it was granted temporary exception until May 1 to regain compliance with Nasdaq's minimum bid price rule.
NRX Pharmaceuticals (NRXP) shares surged 35%. The company's Hope Therapeutics unit plans to acquire the Kadima Neuropsychiatry Institute.
Neumora Therapeutics (NMRA) shares plunged past 81% after a phase 3 trial of navacaprant to treat major depressive disorder failed to meet the primary endpoint.
Comments